UNC Chapel Hill.

PositionStatewide: TRIANGLE REGION

CHAPEL HILL -- UNC Chapel Hill and pharmaceutical company GlaxoSmithKline will establish Qura Therapeutics, a company dedicated to developing treatments for HIV. London-based GSK will invest $20 million over five years in the...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT